QMDx.jpg
QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system
July 09, 2021 02:00 ET | QuantuMDx Group Ltd
QuantuMDx launches Q-POC™ - rapid PCR point of care diagnostic system Roll out at ECCMID 2021 with Q-POC™ SARS-CoV-2 assay96.9% sensitivity, 98.3% specificitySample to result - approximately 30...
QMDx.jpg
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx
February 13, 2021 10:30 ET | QuantuMDx Group Ltd
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx                     -          QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of...
QMDx.jpg
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01
December 22, 2020 07:00 ET | QuantuMDx Group Ltd
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK, 22 December 2020. QuantuMDx Group Limited...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 17, 2020 07:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette       -          Q-POC™ is a point of care molecular diagnostic system which...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 17, 2020 02:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette       -          Q-POC™ is a point of care molecular diagnostic system which...
QMDx.jpg
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette
December 16, 2020 19:00 ET | QuantuMDx Group Ltd
QuantuMDx embarks on £11 million scale-up to mass manufacture its diagnostic Q-POCTM device and disposable test cassette Q-POC™ is a point of care molecular diagnostic system which delivers results...
QMDx.jpg
QuantuMDx Launches Rapid, Sensitive SARS-CoV-2 Test
May 01, 2020 02:00 ET | QuantuMDx Group Ltd
QuantuMDx Launches Rapid, Sensitive SARS-CoV-2 Test Manufacturing in place to produce 2 million tests per week with millions of tests ready to shipEUA application submitted to FDAClinical testing is...
QMDx.jpg
QuantuMDx and Ontera collaborate to advance sepsis diagnosis
December 10, 2019 07:50 ET | QuantuMDx Group Ltd
QuantuMDx and Ontera collaborate to advance sepsis diagnosis Improving outcomes for sepsis patients and promoting antibiotic stewardship NEWCASTLE UPON TYNE, UK/ CALIFORNIA, USA (10 Dec 2019)....
QMDx.jpg
QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (“C&GT”s), to be evaluated by GlaxoSmithKline’s C&GT platform group.
April 17, 2019 02:00 ET | QuantuMDx Group Ltd
Press Release: 17 April 2019 QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies...